Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stratification of obesity phenotypes to optimize future therapy (SOPHIA).
Tahrani AA, Panova-Noeva M, Schloot NC, Hennige AM, Soderberg J, Nadglowski J, Tarasenko L, Ahmad NN, Sleypen BS, Bravo R, Al-Najim W, le Roux CW. Tahrani AA, et al. Among authors: schloot nc. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(10):1031-1039. doi: 10.1080/17474124.2023.2264783. Epub 2023 Oct 24. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37791820 Free article. Review.
Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.
Golomb RC, Tittel SR, Welters A, Karges W, Meyhöfer S, Hummel M, Mader JK, Kämmer JC, Schloot NC, Holl RW. Golomb RC, et al. Among authors: schloot nc. Diabetes Obes Metab. 2025 Feb;27(2):563-573. doi: 10.1111/dom.16048. Epub 2024 Nov 11. Diabetes Obes Metab. 2025. PMID: 39529211 Free PMC article.
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow-Up Registry.
Jung H, Tittel SR, Schloot NC, Heitmann E, Otto T, Lebrec J, Pavel M, Lanzinger S. Jung H, et al. Among authors: schloot nc. Diabetes Obes Metab. 2023 Jul;25(7):1813-1822. doi: 10.1111/dom.15038. Epub 2023 Mar 23. Diabetes Obes Metab. 2023. PMID: 36855221
Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes.
Bakinowska L, Vartak T, Phuthego T, Taylor M, Chandler K, Jerram ST, Williams S, Feldmann M, Johnson DG, Patel KA, Williams AJK, Long AE, Leslie RD, Gillespie KM; Action LADA Consortium; BOX Study Group. Bakinowska L, et al. Diabetes Care. 2023 Apr 1;46(4):714-721. doi: 10.2337/dc22-1317. Diabetes Care. 2023. PMID: 36701208
Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow-up registry.
Welters A, Tittel SR, Reinehr T, Weghuber D, Wiegand S, Karges W, Freiberg C, Meissner T, Schloot NC, Holl RW. Welters A, et al. Among authors: schloot nc. Pediatr Diabetes. 2022 Dec;23(8):1602-1612. doi: 10.1111/pedi.13450. Epub 2022 Nov 27. Pediatr Diabetes. 2022. PMID: 36334008
Ketone bodies: from enemy to friend and guardian angel.
Kolb H, Kempf K, Röhling M, Lenzen-Schulte M, Schloot NC, Martin S. Kolb H, et al. Among authors: schloot nc. BMC Med. 2021 Dec 9;19(1):313. doi: 10.1186/s12916-021-02185-0. BMC Med. 2021. PMID: 34879839 Free PMC article. Review.
101 results